Post-approval studies (Phase 4)Study completedNCT00773513
What this trial is testing
Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)
Who this might be right for
Chronic Renal Anemia
Hoffmann-La Roche 2,825